Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy

• Main Authors: Sripan P., Le Coeur S., Ingsrisawang L., Cressey T., Bouazza N., Foissac F., Ngo-Giang-Huong N., Traisathit P., Srirompotong U., Ayudhaya O., Puangsombat A., Jungpipun J., Jittayanun K., Tréluyer J., Jourdain G., Lallemant M., Urien S.
• 格式: 雜誌
• 出版: 2017
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84991493939&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/42661

© 2016 International Medical Press. Background: Antiretroviral (ARV) regimens used for the prevention of mother-to-child transmission of HIV have evolved over time. We evaluated the contribution of different ARV regimens on the reduction of the plasma HIV RNA viral load (VL) during pregnancy. Method...